A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)
Conditions: Plaque Psoriasis; Non-alcoholic Fatty Liver Disease Interventions: Biological: Investigational Arm - secukinumab; Biological: Control Arm - placebo Sponsor: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alcoholism | Fatty Liver Disease (FLD) | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Psoriasis | Research | Study | Urology & Nephrology